Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 625 of 1,261
  1. US 9683236

    Modulation of huntingtin expression

    Ionis Pharmaceuticals, Inc. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  2. US 9682922

    Biodegradable lipids for the delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  3. US 9682069

    Methods of treating Dravet syndrome

    OVID THERAPEUTICS INC. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  4. US 9683269

    Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  5. US 9683263

    Detection and treatment of irritable bowel syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  6. US 9683024

    Recombinantly expressed plasmodium CelTOS antigen and methods of use thereof

    The United States of America as represented by the Secretary of the Army · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  7. US 9683235

    Compositions for modulating Tau expression

    Ionis Pharmaceuticals, Inc. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  8. US 9683009

    Bone-selective osteogenic oxysterol-bone targeting agents

    The Regents of the University of California · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  9. US 9683025

    Methods and compositions for treating cancer and inflammatory diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  10. US 9682982

    Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  11. US 9682976

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  12. US 9682925

    Cyclopropaneamine compound

    Takeda Pharmaceutical Company Limited · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  13. US 9682934

    Modified amino acids

    Sutro Biopharma, Inc. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  14. US 9682175

    Coating material and medical device system including same

    ATRIUM MEDICAL CORPORATION · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  15. US 9682139

    Lipids and compositions for the delivery of therapeutics

    ARBUTUS BIOPHARMA CORPORATION · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  16. US 9682153

    Polymer conjugates of therapeutic peptides

    Nektar Therapeutics · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  17. US 9682145

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  18. US 9682106

    Method for combined conditioning and chemoselection in a single cycle

    The Regents of the University of California · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  19. US 9682116

    Date pit composition for the treatment of animals

    UNITED ARAB EMIRATES UNIVERSITY · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  20. US 9682988

    Solid salt form of α-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof

    Nektar Therapeutics · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  21. US 9682132

    Compositions and methods relating to argininosucccinate synthetase

    BANYAN BIOMARKERS, INC. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  22. US 9682097

    Oligonucleotide analogues targeting human LMNA

    Sarepta Therapeutics, Inc. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  23. US 9682088

    Method for treating uterine fibroids

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  24. US 9682080

    Pyruvate kinase activators for use in therapy

    Agios Pharmaceuticals, Inc. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.